Story perspectives

AI Revolutionizes Pharma: Boosting Efficiency and Compliance

9/11/2025

Summary

AI Enhancing Pharma

The bio/pharmaceutical industry is evolving through enhanced data and AI capabilities, according to Toni Manzano at the PDA Regulatory Conference 2025.
AI boosts drug discovery and manufacturing, improving efficiency and patient safety in human plasma management and quality control.
Over 25% of FDA warning letters address data accuracy issues, emphasizing the importance of data management for effective AI use.
Jessica Laham pointed out AI's role in legal and compliance, highlighting the necessity for ethical considerations.
Legislative frameworks, like the EU's AI risk classification, are crucial for addressing industry-related risks.

History

Historical Context

The 21st Century Cures Act, enacted in 2016, aimed to enhance medical product development and patient access to therapies. However, the FDA reported that over 25% of its warning letters in 2020 were due to data accuracy issues. As AI technologies evolve, discussions on their role in drug discovery emphasize the urgent need for robust data governance in the pharmaceutical sector.

1 of 2

AI Enhancing Pharma

The bio/pharmaceutical industry is evolving through enhanced data and AI capabilities, according to Toni Manzano at the PDA Regulatory Conference 2025.
AI boosts drug discovery and manufacturing, improving efficiency and patient safety in human plasma management and quality control.
Over 25% of FDA warning letters address data accuracy issues, emphasizing the importance of data management for effective AI use.
Jessica Laham pointed out AI's role in legal and compliance, highlighting the necessity for ethical considerations.
Legislative frameworks, like the EU's AI risk classification, are crucial for addressing industry-related risks.

1 / 2